Skip to content
10-Q

Quarterly Report

QLY BIOTECH GROUP CORP.

0001477932-21-004506

← back to feed
Filed
Jul 9, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Jul 8, 2021 3.9M sh
Capex Q3 2021 · May 31, 2021 $0
Capex restated Q3 2021 · May 31, 2020 $5.14K
Current Liabilities Q3 2021 · May 31, 2021 $21.6K
Current Liabilities Q3 2021 · Aug 31, 2020 $7.8K
Total Liabilities Q3 2021 · May 31, 2021 $21.6K
Total Liabilities Q3 2021 · Aug 31, 2020 $7.8K
Current Assets Q3 2021 · May 31, 2021 $12.62K
Current Assets Q3 2021 · Aug 31, 2020 $27.63K
Total Assets Q3 2021 · May 31, 2021 $15.04K
Total Assets Q3 2021 · Aug 31, 2020 $31.34K
Operating Cash Flow Q3 2021 · May 31, 2020 −$2.52K
Cash And Equivalents Q3 2021 · May 31, 2020 $2.16K
Cash And Equivalents Q3 2021 · Aug 31, 2019 $5K
Stockholders Equity Q3 2021 · May 31, 2020 −$1.51K
Stockholders Equity Q3 2021 · Aug 31, 2019 $2.02K
Sga Expense Q3 2021 · May 31, 2020 $1.63K
Sga Expense Q3 2021 · May 31, 2020 $6.13K
Net Income Q3 2021 · May 31, 2020 −$1.63K
Net Income Q3 2021 · May 31, 2020 −$3.53K
Revenue Q3 2021 · May 31, 2020 $0
Revenue Q3 2021 · May 31, 2020 $4K